185 related articles for article (PubMed ID: 28991708)
1. Post-cART progressive multifocal leukoencephalopathy era in a Brazilian center.
Lima MA; Silva MTT; Afonso LA; Vaz BJP
J Neurol Sci; 2017 Oct; 381():321-324. PubMed ID: 28991708
[TBL] [Abstract][Full Text] [Related]
2. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.
Khanna N; Elzi L; Mueller NJ; Garzoni C; Cavassini M; Fux CA; Vernazza P; Bernasconi E; Battegay M; Hirsch HH;
Clin Infect Dis; 2009 May; 48(10):1459-66. PubMed ID: 19348592
[TBL] [Abstract][Full Text] [Related]
3. Clinical Profile and Outcome of Progressive Multifocal Leukoencephalopathy in HIV Infected Indian Patients.
Shah V; Toshniwal H; Shevkani M
J Assoc Physicians India; 2017 Mar; 65(3):40-44. PubMed ID: 28462542
[TBL] [Abstract][Full Text] [Related]
4. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
[TBL] [Abstract][Full Text] [Related]
5. Not a Disease of the Past: A Case Series of Progressive Multifocal Leukoencephalopathy in the Established Antiretroviral Era.
Summers NA; Kelley CF; Armstrong W; Marconi VC; Nguyen ML
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):544-552. PubMed ID: 30834775
[TBL] [Abstract][Full Text] [Related]
6. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study.
Engsig FN; Hansen AB; Omland LH; Kronborg G; Gerstoft J; Laursen AL; Pedersen C; Mogensen CB; Nielsen L; Obel N
J Infect Dis; 2009 Jan; 199(1):77-83. PubMed ID: 19007313
[TBL] [Abstract][Full Text] [Related]
7. Immune Reconstitution Inflammatory Syndrome Unmasking or Worsening AIDS-Related Progressive Multifocal Leukoencephalopathy: A Literature Review.
Fournier A; Martin-Blondel G; Lechapt-Zalcman E; Dina J; Kazemi A; Verdon R; Mortier E; de La Blanchardière A
Front Immunol; 2017; 8():577. PubMed ID: 28588577
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretroviral therapy.
Gasnault J; Taoufik Y; Goujard C; Kousignian P; Abbed K; Boue F; Dussaix E; Delfraissy JF
J Neurovirol; 1999 Aug; 5(4):421-9. PubMed ID: 10463864
[TBL] [Abstract][Full Text] [Related]
10. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection.
Inui K; Miyagawa H; Sashihara J; Miyoshi H; Tanaka-Taya K; Nishigaki T; Teraoka S; Mano T; Ono J; Okada S
Brain Dev; 1999 Sep; 21(6):416-9. PubMed ID: 10487477
[TBL] [Abstract][Full Text] [Related]
11. Acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome: prevalence, main characteristics, and outcomes in a Brazilian center.
Santana MN; Ferrari R; Macedo AC; Marcusso RMN; Fernandes RA; Vidal JE
Arq Neuropsiquiatr; 2023 Oct; 81(10):883-890. PubMed ID: 37899047
[TBL] [Abstract][Full Text] [Related]
12. Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy.
Gasnault J; Costagliola D; Hendel-Chavez H; Dulioust A; Pakianather S; Mazet AA; de Goer de Herve MG; Lancar R; Lascaux AS; Porte L; Delfraissy JF; Taoufik Y;
PLoS One; 2011; 6(6):e20967. PubMed ID: 21738597
[TBL] [Abstract][Full Text] [Related]
13. Survival and prognostic factors of progressive multifocal leukoencephalopathy in people living with HIV in modern ART era.
Jiang R; Song Z; Liu L; Mei X; Sun J; Qi T; Wang Z; Song W; Tang Y; Yang J; Xu S; Zhao B; Shen Y; Zhang R; Chen J
Front Cell Infect Microbiol; 2023; 13():1208155. PubMed ID: 38029233
[TBL] [Abstract][Full Text] [Related]
14. Progressive multifocal leukoencephalopathy in patients with immunovirological control and at least 6 months of combination antiretroviral therapy.
Dalla-Pozza P; Hentzien M; Allavena C; Doe de Maindreville A; Bouiller K; Valantin MA; Lafont E; Zaegel-Faucher O; Cheret A; Martin-Blondel G; Cotte L; Bani-Sadr F;
AIDS; 2022 Mar; 36(4):539-549. PubMed ID: 34873087
[TBL] [Abstract][Full Text] [Related]
15. In situ evidence of JC virus control by CD8+ T cells in PML-IRIS during HIV infection.
Martin-Blondel G; Bauer J; Cuvinciuc V; Uro-Coste E; Debard A; Massip P; Delisle MB; Lassmann H; Marchou B; Mars LT; Liblau RS
Neurology; 2013 Sep; 81(11):964-70. PubMed ID: 23935178
[TBL] [Abstract][Full Text] [Related]
16. Treatment options for AIDS patients with progressive multifocal leukoencephalopathy.
Hernández B; Dronda F; Moreno S
Expert Opin Pharmacother; 2009 Feb; 10(3):403-16. PubMed ID: 19191678
[TBL] [Abstract][Full Text] [Related]
17. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.
Falcó V; Olmo M; del Saz SV; Guelar A; Santos JR; Gutiérrez M; Colomer D; Deig E; Mateo G; Montero M; Pedrol E; Podzamczer D; Domingo P; Llibre JM
J Acquir Immune Defic Syndr; 2008 Sep; 49(1):26-31. PubMed ID: 18667930
[TBL] [Abstract][Full Text] [Related]
18. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
[TBL] [Abstract][Full Text] [Related]
19. JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy.
Khanna N; Wolbers M; Mueller NJ; Garzoni C; Du Pasquier RA; Fux CA; Vernazza P; Bernasconi E; Viscidi R; Battegay M; Hirsch HH;
J Virol; 2009 May; 83(9):4404-11. PubMed ID: 19211737
[TBL] [Abstract][Full Text] [Related]
20. Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).
Melliez H; Mary-Krause M; Bocket L; Guiguet M; Abgrall S; De Truchis P; Katlama C; Martin-Blondel G; Henn A; Revest M; Robineau O; Khuong-Josses MA; Canestri A; De Castro N; Joly V; Mokhtari S; Risso K; Gasnault J; Costagliola D;
Clin Infect Dis; 2018 Jul; 67(2):275-282. PubMed ID: 29635465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
